Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial
Single-use only: EasyTouch insulin syringes are designed for single use only reuse of needles increases the risk of infection, needle dulling, and inaccurate dosing
This focus on family-centered care reflects Wellstars commitment to supporting people at every stage of lifeensuring families have access to compassionate, specialized care when they need it most
In comparison to Tirzepatide (Zepbound), which delivers impressive results, the TRIUMPH-1 trial indicated Retatrutide's potent potential, with a 28.3% weight reduction over 80 weeks for the highest 12 mg dose